Results for tag: "Hyperthyroidism Drug"

The Hyperthyroidism Drug market is a segment of the Endocrine and Metabolic Disorders Drugs market. Hyperthyroidism is a condition in which the thyroid gland produces too much of the hormone thyroxine, leading to an overactive metabolism. Common treatments for hyperthyroidism include antithyroid drugs, radioactive iodine, and surgery. Antithyroid drugs are the most commonly prescribed treatment, and are used to reduce the production of thyroxine. The Hyperthyroidism Drug market is highly competitive, with a number of large and small players. Companies in the market are focused on developing new drugs and treatments to meet the needs of patients. Many of these companies are also investing in research and development to improve existing treatments and develop new ones. Some of the major companies in the Hyperthyroidism Drug market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, and Takeda. Show Less Read more